An illustration of the Vagus nerve, which is part of the autonomic nervous system. Sebastian Kaulitzki/Science Photo Library RF/Getty Images hide caption
multiple sclerosis multiple sclerosis
Stories About
multiple sclerosis
Selma Blair arrives at the second annual Academy Museum gala at the Academy Museum of Motion Pictures on Saturday, Oct. 15, 2022, in Los Angeles. Jordan Strauss/Jordan Strauss/Invision/AP hide caption
This image from an electron microscope shows a cross-sectional view of an oligodendrocyte (blue) among nerve fibers coated with myelin (dark red). In models of autism spectrum disorder, oligodendrocytes appear to create too much or too little myelin. Jose Luis Calvo/Science Source hide caption
Researchers Link Autism To A System That Insulates Brain Wiring
Generics may not have the same cost-lowering power for specialty medicines, such as multiple sclerosis drugs, researchers find. That's true especially when other brand-name drugs are approved to treat a given disease before the first generic is approved. Gary Waters/Ikon Images/Getty Images hide caption
A scanning electron micrograph shows microglial cells (yellow) ingesting branched oligodendrocyte cells (purple), a process thought to occur in multiple sclerosis. Oligodendrocytes form insulating myelin sheaths around nerve axons in the central nervous system. Dr. John Zajicek/Science Source hide caption
Shereese Hickson was diagnosed with multiple sclerosis in 2012 and is unable to work. She supports herself and her son, Isaiah, on $770 a month. Shane Wynn for KHN hide caption
Chronically Ill, Traumatically Billed: $123,019 For 2 Multiple Sclerosis Treatments
The Genetic Information Nondiscrimination Act still prohibits your insurer from using the results of genetic tests against you. But the ACA's additional protections may be in doubt if certain states get their way. Gary Waters/Ikon Images/Getty Images hide caption
As the price of specialty drugs continues to rise, some health plans are shifting more of the cost to patients. Getty Images hide caption
Dr. Carla Rossotti (left), a general practitioner, and her health care team leave the home of the their patient, 37-year-old Osvaldo Daniel Martinez. He has the symptoms of a degenerative disease, Rossotti says, but he needs a neurologist's evaluation before he can get proper treatment. Sarah Varney/Kaiser Health News hide caption
For One Father And Son In Puerto Rico, A Storm Was Just The Latest Trial
Alzheimer's disease causes atrophy of brain tissue. The discovery that lymph vessels near the brain's surface help remove waste suggests glitches in the lymph system might be involved in Alzheimer's and a variety of other brain diseases. Alfred Pasieka/Science Source hide caption
Brain's Link To Immune System Might Help Explain Alzheimer's
Here's a kale salad and sweet potato that did get their portraits taken in the name of medical research. Courtesy of Brandie Jefferson hide caption
Eating: it's what I was born to do apparently! Courtesy of Brandie Jefferson hide caption
Brandie Jefferson Courtesy of Lopestagram/Instagram hide caption
Gilead Sciences' Harvoni can cure hepatitis C, but the drug costs a fortune. Lloyd Fox/Baltimore Sun/TNS via Getty Images hide caption
As His Mother's Multiple Sclerosis Progresses, A Son Shifts To Caregiver
Multiple Sclerosis Patients Stressed Out By Soaring Drug Costs
Jason DaSilva was on a family vacation in 2006 when he fell and couldn't get up. His multiple sclerosis symptoms have progressed to the point that he can't walk. Factory Release hide caption
A collage of family photos of Melissa Sherak Glasser. Mark Turner for NPR hide caption
Pregnancy Hormone May Reduce Multiple Sclerosis Symptoms
French multiple sclerosis sufferer Marc Kopp speaks about his quest to skydive over Mount Everest, in an interview conducted in Kathmandu last week. Prakash Mathema/AFP/Getty Images hide caption
Spring has brought the stork and a baby who just might have a higher risk for multiple sclerosis later in life. Anna Bryukhanova/iStockphoto.com hide caption
Moshe Rute smokes marijuana at the Hadarim nursing home in Kibutz Naan, Israel, in early March. The Israeli government and a private company are distributing cannabis for medicinal purposes to more than 1,800 people in Israel. Uriel Sinai/Getty Images hide caption